PB2276: MAHOGANY: A PHASE 3 TRIAL OF ZANUBRUTINIB PLUS ANTI-CD20 ANTIBODIES VS LENALIDOMIDE PLUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR OR MARGINAL ZONE LYMPHOMA

Bibliographic Details
Main Authors:	Antonio Salar Silvestre, Judith Trotman, Clementine Sarkozy, Yuqin Song, Laurie H. Sehn, Loretta J. Nastoupil, Wanhua Zhang, Pierre Fustier, Richard Delarue, Pier Luigi Zinzani
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000975836.58931.97

Internet